Is multiple myeloma curable?

Treatment for multiple myeloma can often help control symptoms and improve quality of life. But myeloma usually can’t be cured, which means additional treatment is needed when the cancer comes back.

What does DARZALEX treat?

DARZALEX® (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. DARZALEX® is not chemotherapy. It is a targeted monoclonal antibody that helps slow or stop the progression of multiple myeloma in several ways.

What is the cost of daratumumab?

However, daratumumab is a costly drug, priced at nearly $6,500 per infusion; as a result, it is unclear whether it provides sufficient value in this clinical setting.

What are the side effects of lenalidomide?

The most common side effects of REVLIMID include:

• diarrhea.
• rash.
• nausea.
• constipation.
• tiredness or weakness.
• fever.
• itching.

How good is daratumumab?

Daratumumab, Lenalidomide, and Dexamethasone The overall response rate was 81%, with 34% of patients achieving a complete response or better and 63% achieving a very good partial response (VGPR) or better. The median response duration was not reached, and 91% of patients were free of disease progression at 12 months.

How long can you stay on lenalidomide?

The median duration of lenalidomide maintenance was 21 months, with 25% of patients receiving <11 months of maintenance and 25% with treatment longer than 31 months. The treatment had been discontinued in 64.7% (n = 90) of the patients when the analysis was performed.

Is lenalidomide a chemo?

Lenalidomide is a cancer drug and is also known by its brand name, Revlimid. It is a treatment for myeloma and blood disorders called myelodysplastic syndromes. You may also have it as part of clinical trials for other types of cancer. For myeloma, you might have lenalidomide with a steroid drug called dexamethasone.

Can DARZALEX cure multiple myeloma?

Although Darzalex cannot cure multiple myeloma it can improve the quality and length of life in most people. Unfortunately, there is currently no cure for multiple myeloma. However, the cancer can be managed successfully in many patients for years. Darzalex is a monoclonal antibody.

What is the life expectancy of someone with multiple myeloma?

Multiple myeloma is an uncommon cancer of the blood. The median length of survival after diagnosis with multiple myeloma is 62 months for Stage I, 44 months for Stage II, and 29 months for Stage III. Life expectancy depends on many factors, including the person’s age, health, kidney function, and more.

Does lenalidomide affect memory?

Lenalidomide may induce particular cognitive disorders (notably episodic memory impairments) in some patients. The drug’s putative neurotoxicity is probably promoted by specific risk factors (such as previous chemotherapy, prior mild cognitive impairment, age and the presence of cerebrovascular lesions).